Concepedia

Kaushik Sarma

KS

Statistics

Publications

10

Citations

1.2K

H-Index

10

Active since

2012

Affiliations

Vion Pharmaceuticals (United States)(Current)

Sunovion (United States)

Sunovion (United Kingdom)

Kaushik Sarma is an author at Vion Pharmaceuticals (United States) specializing in psychopharmacology, pharmacotherapy, and antipsychotic pharmacotherapy.

Publications per year

2012–2018

10

Publications

10

Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study

Antony Loebel, Josephine Cucchiaro, Robert Silva et al. · American Journal of Psychiatry · 2013 · 340 citations

, , +17

Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study

Antony Loebel, Josephine Cucchiaro, Robert Silva et al. · American Journal of Psychiatry · 2013 · 292 citations

, , +17

Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: A randomized, double-blind, placebo- and active-controlled trial

Antony Loebel, Josephine Cucchiaro, Kaushik Sarma et al. · Schizophrenia Research · 2013 · 172 citations · Full text

, , +17

Long-term safety and tolerability of lurasidone in schizophrenia

Leslie Citrome, Josephine Cucchiaro, Kaushik Sarma et al. · International Clinical Psychopharmacology · 2012 · 120 citations

, , +17

Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study

Antony Loebel, Josephine Cucchiaro, Jane Xu et al. · Schizophrenia Research · 2013 · 118 citations · Full text

, , +17

1–5 of 10